Clinical trial No longer in our active list Observational Ages 18 to 90

Establishing a bronchiectasis patient registry in China

Official title: The Establishment of China Bronchiectasis Registry and the Optimal Treatment Research Collaboration for Bronchiectasis (BEChina)

Run by Shanghai Pulmonary Hospital, Shanghai, China · NCT03643653 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is creating a patient registry for people with bronchiectasis in China to gather information that can help improve treatment and understanding of the disease.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment10000 (estimated)
SponsorShanghai Pulmonary Hospital, Shanghai, China
Academic / other
Locations2 sites (Shanghai, Shanghai and 1 other locations)
Trial IDNCT03643653 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are patients diagnosed with bronchiectasis who are willing to participate and provide necessary medical information.

Probably not a fit

Patients under 18 years old or those with incomplete essential medical information will not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative aims to create a multi-centered registry for patients with bronchiectasis across China, starting with three teaching hospitals in Shanghai. The registry will collect detailed patient information and follow-up data to enhance understanding of the disease's prognosis. It will also facilitate the initiation of optimal treatment studies based on the collected data. The project seeks to promote clinical research and education in bronchiectasis through collaboration and sharing of expertise among participating institutions.

Why it matters

Potential benefit: If successful, this registry could lead to improved understanding and management of bronchiectasis in patients across China.

How similar studies have gone: While this approach is novel in China, similar registries in other countries have shown success in improving patient outcomes and advancing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with bronchiectasis according to 'non-cystic fibrosis bronchiectasis guideline' published by British Thoracic Society in 2010.
* Patients who are willing to sign the consent form and participate in the study.

Exclusion Criteria:

* Patients with incomplete essential information, which is needed for the integrity of data analysis. Essential information include CT images, respiratory sample cultures, spirometry and exacerbation history for at least one year.
* Patients under 18 years old.

Where it's running

  • Shanghai Pulmonary Hospital , Tongji University
    Shanghai, Shanghai, China
    Recruiting
  • Ruijin Hospital
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.